Murli Krishna Pharma Private Limited

Murli Krishna Pharma Private Ltd. is a 20-year-old Indian organization that provides a range of innovative solutions to optimize the delivery of pharmaceutical preparations. With accreditations of EUMGP, WHO-GMP, GCC, and Jordanian FDA. Our extensive product portfolio encompasses a wide array of Pre-Finished Formulations (PFIs) of oral solid dosage formulations including pellets, Micro-pellets, Extrudes, Granules, and MUPS. It boasts modern machinery and art of facilities (100% EOU) compliant with 21 CFR, part 11 standards. Encompasses of regulatory documents support along with ECTD formats. Currently, commercially active in more than 50 countries with more than 200 formulators.

Finished Dosage Forms are manufactured employing Micro and Nano emulsions. The formulations developed are in the form of Oral Solid dosage, Injectable, Ophthalmic Preparations, and Transdermal Lotions.

Murli Krishna Pharma pioneered the introduction of Transdermal Fortified Iron Liposomal Lotion as a branded formulation that caters to treating Anaemia through a metered dose administration. This is a platform technology and will be extended for administering calcium, folate, B12, and D3. We have also developed soft administered Nano Emulsions of Corticosteroids, using a patent non-infringing device.

Murli Krishna Pharma also renders Contract Research and Manufacturing Services (CRAMS), and has successfully undertaken Contract Research Projects from US and European organizations.